Editorial Board

Editor-in-Chief

  1. Professor, Laboratory Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands

Editorial Board Member

  1. Fred Wyszkowski Cancer Research Laboratory, Technion - Israel Institute of Technology, Haifa, Israel
  2. Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, United States
  3. Department of Biomedical Sciences, Faculty of Medicine, University of Namur, Namur, Belgium
  4. Lab Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands; Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, Pisa, Italy
  5. Cancer Biology Laboratory, Lutheran University of Brazil, Canoas, Brazil
  6. Department of Rheumatology, Amsterdam Rheumatology and immunology Center (ARC), Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
  7. Division of Medical Oncology, University of Basel, Basel, Switzerland
  8. Institute of Pharmacy, University of Bonn, Bonn, Germany
  9. Faculty of Health Sciences, University of Macau, Macau, China
  10. Molecular Pharmacology, School of Pharmaceutical Sciences (EPGL), University of Geneva, Geneva, Switzerland
  11. Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, United States
  12. Division of Medicine, Roswell Park Cancer Institute, Buffalo, NY, United States
  13. Section of Internal Medicine, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
  14. Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy
  15. School of Pharmacy, University of Huddersfield, Huddersfield, United Kingdom
  16. Department of Genetics, Physical Anthropology and Animal Physiology (School of Medicine) of the University of the Basque Country (UPV/EHU), Basque Country, Spain
  17. Nova Medical School (NMS), Universidade Nova de Lisboa/Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal
  18. Division of Pharmaceutics & Pharmaceutical Chemistry College of Pharmacy, The Ohio State University, Columbus, OH, United States
  19. Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité – Universitätsmedizin und Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany
  20. Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan
  21. Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, AL, United States
  22. Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan
  23. Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Cancer Drug Resistance
Partners
Copyright © 2018 OAE Publishing Inc. All Rights Reserved.